Lexicon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,750 | $1,647 | $1,130 | $702 |
Gross Profit | 1,679 | 1,481 | 955 | 485 |
EBITDA | -60,123 | -51,079 | -44,453 | -44,188 |
EBIT | -60,249 | -51,218 | -44,597 | -44,335 |
Net Income | -64,811 | -53,429 | -48,397 | -48,244 |
Net Change In Cash | 1,750 | 1,647 | 1,130 | 702 |
Free Cash Flow | -53,926 | -48,790 | -55,130 | -50,548 |
Cash | 34,551 | 35,617 | 96,494 | 22,465 |
Basic Shares | 361,492 | 310,836 | 245,390 | 244,925 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,204 | $139 | $298 | $23,995 |
Gross Profit | 1,119 | -288 | -54,748 | 22,066 |
EBITDA | -163,464 | -98,737 | -86,664 | -41,095 |
EBIT | -164,018 | -99,164 | -86,956 | -44,029 |
Net Income | -177,119 | -103,128 | -88,268 | -70,184 |
Net Change In Cash | 1,204 | 139 | 298 | 23,995 |
Cost of Revenue | -17,720 | -62,198 | 90,151 | |
Free Cash Flow | -162,367 | -90,177 | -88,238 | -143,056 |
Cash | 22,465 | 46,345 | 64,065 | 126,263 |
Basic Shares | 221,130 | 165,733 | 145,652 | 110,841 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.17 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.20 |
